12:00 AM
Feb 23, 2009
 |  BioCentury  |  Emerging Company Profile

Corporate Profile

CT Atlantic AG

Zurich, Switzerland

Technology: Platform for developing immunotherapies from human-derived antibodies

Disease focus: Cancer

Read the full 59 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >